| 中文名称 | 阿西美辛 |
|---|---|
| 中文别名 | 阿西美辛;1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-乙酸羧甲基酯;醋炎痛;炎痛美新;乙酰消炎痛;1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-乙酸羧甲酯;消炎痛醋酯;阿西美辛 GMP;阿西美辛 EP标准品;阿西美辛-D4;阿西美辛标准品;阿西美辛杂质混合物 EP标准品;[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基吲哚-3-基]乙酰氧基乙酸;1-(4-氯苯甲酰基)-5-甲氧基-2-甲基吲哚-3-乙酸羧甲基酯;1-(对氯苯甲酰基)-5-甲氧基-2-甲基吲哚-3-乙酸羧甲酯;阿西美辛杂质混合 |
| 英文名称 | Acemetacin |
| 英文别名 | [1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-ACETIC ACID CARBOXYMETHYL ESTER;1-[P-CHLOROBENZOYL]-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID CARBOXYMETHYL ESTER;ACEMETACIN;AURORA KA-6229;((1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)aceticacid;(1-(p-chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy)essigsaeure;1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-aceticacicarboxymethyl;1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-aceticacidcarboxymethyl;2-(2-(1-(p-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)aceticacid;acemetacinum;acemix;aximeixin;k-708;rantudil;rheumibis;tv1322;1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic Acid Carboxymethyl Ester;Emflex;Solart;1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetic aci carboxymethyl ((1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)acetic acid (1-(p-chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy)essigsaeure 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetic acid carboxymethyl 2-(2-(1-(p-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)acetic acid acemetacin acemetacinum acemix;2-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetoxy)acetic acid;[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetoxyacetic Acid;1-(4-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic Acid Carboxymethyl Ester;1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid carboxymethyl ester;BAY f4975;glycolic acid ester of indomethacin;TVX-1322;TVX 1322;HMS3372K20;SR-01000000070;AB03974;TV-1322;[1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxy]-acetic acid;KBioGR_001285;ACEMETACIN [WHO-DD];BSPBio_003316;BS-16970;AB00052149;Acemetacina;Bay-f-4975;KBio3_002818;NCGC00022084-06;Spectrum2_001162;Tox21_113473;Prestwick_669;ACEMETACIN [INN];Spectrum5_001385;CCG-39550;KBio1_000490;((1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetoxy)acetic acid;ACEMETACIN [MART.];Prestwick1_000296;53164-05-9;D01582;BRN 0501672;NINDS_000490;NCGC00022084-07;BRD-K67563174-001-05-1;Spectrum3_001868;SCHEMBL23843;{2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetoxy}acetic acid;from D:/data/P.Sapui/gsas_26052012/ps1.cif;HMS1568L14;HMS2230G08;Spectrum_000428;ACEMETACIN [JAN];NCGC00016868-06;CHEMBL189171;BDBM50336272;NCGC00022084-05;Acemetacin (JP17/INN);SR-01000000070-2;A936725;indometacin carboxymethyl ester;2-[2-[1-(4-chloro-2,3,5,6-tetradeuteriobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid;Prestwick0_000296;s2602;K 708;BRD-K67563174-001-09-3;Acemetacina [INN-Spanish];Rantudil (TN);NCGC00022084-04;KBio2_000908;AKOS015895194;AB00052149-15;MLS000028440;Acemetacine [INN-French];1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, carboxymethyl ester;KBioSS_000908;ACEMETACIN [EP MONOGRAPH];BCP13127;NS00000533;NCGC00016868-09;EINECS 258-403-4;5-22-05-00241 (Beilstein Handbook Reference);SPBio_001143;1-(p-Chlorobenz... |
| CAS No. | 53164-05-9 |
| 分子式 | C21H18ClNO6 |
| 分子量 | 415.82 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学